Abstract CT113: Preliminary Data on a Phase 1b, First-in-human Study of the Allosteric Extracellular FGFR2 Inhibitor Alofanib in Patients with Refractory Metastatic Gastric Cancer
Cancer Research(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要